Soluble tumor necrosis factor receptor 1 level is associated with left ventricular hypertrophy: The northern manhattan study

Yasuyoshi Takei, Marco R. Di Tullio, Shunichi Homma, Bernadette Boden-Albala, Tatjana Rundek, Ralph L Sacco, Grace Berry, Rui Liu, Zhezhen Jin, Kazuo Eguchi, Mitchell S V Elkind

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

BackgroundAlthough inflammatory markers may be associated with risk of cardiovascular events, few data are available regarding these markers and their association with left ventricular hypertrophy (LVH). We sought to evaluate whether inflammatory markers were independently associated with LVH in a multiethnic population in northern Manhattan.MethodsA population-based cross-sectional study was conducted in 660 participants without stroke, who had undergone both transthoracic echocardiography and testing for soluble tumor necrosis factor receptor (sTNFR) 1, interleukin (IL)-6, and high-sensitivity C-reactive protein (hsCRP). LV mass was calculated according to an established formula. LVH was defined as LV mass >90th percentile of the participants.ResultsThe mean age was 67.4 ± 8.8 years, 35.5% were men, 61.7% were Hispanic, 19.7% were black, and 18.6% were white. In univariate analyses, hsCRP, IL-6, and sTNFR1 were significantly associated with LV mass. Multiple linear regression analyses demonstrated that sTNFR1 (P ≤ 0.0008) was associated with LV mass after adjusting for demographic and medical risk factors, but hsCRP and IL-6 were not. When all markers were included in the same model, sTNFR1 remained significant, but hsCRP and IL-6 did not. Compared with the lowest quartile of sTNFR1, those in the highest quartile were more likely to have LVH (odds ratio ≤ 1.84, 95% confidence interval, 0.97-3.64, P ≤ 0.06).ConclusionssTNFR1, but not hsCRP nor IL-6, is independently associated with increased LV mass. Chronic subclinical inflammation including the TNFR1-associated system may contribute to LVH.

Original languageEnglish
Pages (from-to)763-769
Number of pages7
JournalAmerican Journal of Hypertension
Volume22
Issue number7
DOIs
StatePublished - Jul 1 2009

Fingerprint

Tumor Necrosis Factor Receptors
Left Ventricular Hypertrophy
C-Reactive Protein
Interleukin-6
Receptors, Tumor Necrosis Factor, Type I
Hispanic Americans
Population
Echocardiography
Linear Models
Cross-Sectional Studies
Stroke
Odds Ratio
Regression Analysis
Demography
Confidence Intervals
Inflammation

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Soluble tumor necrosis factor receptor 1 level is associated with left ventricular hypertrophy : The northern manhattan study. / Takei, Yasuyoshi; Di Tullio, Marco R.; Homma, Shunichi; Boden-Albala, Bernadette; Rundek, Tatjana; Sacco, Ralph L; Berry, Grace; Liu, Rui; Jin, Zhezhen; Eguchi, Kazuo; Elkind, Mitchell S V.

In: American Journal of Hypertension, Vol. 22, No. 7, 01.07.2009, p. 763-769.

Research output: Contribution to journalArticle

Takei, Y, Di Tullio, MR, Homma, S, Boden-Albala, B, Rundek, T, Sacco, RL, Berry, G, Liu, R, Jin, Z, Eguchi, K & Elkind, MSV 2009, 'Soluble tumor necrosis factor receptor 1 level is associated with left ventricular hypertrophy: The northern manhattan study', American Journal of Hypertension, vol. 22, no. 7, pp. 763-769. https://doi.org/10.1038/ajh.2009.79
Takei, Yasuyoshi ; Di Tullio, Marco R. ; Homma, Shunichi ; Boden-Albala, Bernadette ; Rundek, Tatjana ; Sacco, Ralph L ; Berry, Grace ; Liu, Rui ; Jin, Zhezhen ; Eguchi, Kazuo ; Elkind, Mitchell S V. / Soluble tumor necrosis factor receptor 1 level is associated with left ventricular hypertrophy : The northern manhattan study. In: American Journal of Hypertension. 2009 ; Vol. 22, No. 7. pp. 763-769.
@article{0d94558fe576475b9a55be0114757bfe,
title = "Soluble tumor necrosis factor receptor 1 level is associated with left ventricular hypertrophy: The northern manhattan study",
abstract = "BackgroundAlthough inflammatory markers may be associated with risk of cardiovascular events, few data are available regarding these markers and their association with left ventricular hypertrophy (LVH). We sought to evaluate whether inflammatory markers were independently associated with LVH in a multiethnic population in northern Manhattan.MethodsA population-based cross-sectional study was conducted in 660 participants without stroke, who had undergone both transthoracic echocardiography and testing for soluble tumor necrosis factor receptor (sTNFR) 1, interleukin (IL)-6, and high-sensitivity C-reactive protein (hsCRP). LV mass was calculated according to an established formula. LVH was defined as LV mass >90th percentile of the participants.ResultsThe mean age was 67.4 ± 8.8 years, 35.5{\%} were men, 61.7{\%} were Hispanic, 19.7{\%} were black, and 18.6{\%} were white. In univariate analyses, hsCRP, IL-6, and sTNFR1 were significantly associated with LV mass. Multiple linear regression analyses demonstrated that sTNFR1 (P ≤ 0.0008) was associated with LV mass after adjusting for demographic and medical risk factors, but hsCRP and IL-6 were not. When all markers were included in the same model, sTNFR1 remained significant, but hsCRP and IL-6 did not. Compared with the lowest quartile of sTNFR1, those in the highest quartile were more likely to have LVH (odds ratio ≤ 1.84, 95{\%} confidence interval, 0.97-3.64, P ≤ 0.06).ConclusionssTNFR1, but not hsCRP nor IL-6, is independently associated with increased LV mass. Chronic subclinical inflammation including the TNFR1-associated system may contribute to LVH.",
author = "Yasuyoshi Takei and {Di Tullio}, {Marco R.} and Shunichi Homma and Bernadette Boden-Albala and Tatjana Rundek and Sacco, {Ralph L} and Grace Berry and Rui Liu and Zhezhen Jin and Kazuo Eguchi and Elkind, {Mitchell S V}",
year = "2009",
month = "7",
day = "1",
doi = "10.1038/ajh.2009.79",
language = "English",
volume = "22",
pages = "763--769",
journal = "Journal of clinical hypertension",
issn = "0895-7061",
publisher = "Oxford University Press",
number = "7",

}

TY - JOUR

T1 - Soluble tumor necrosis factor receptor 1 level is associated with left ventricular hypertrophy

T2 - The northern manhattan study

AU - Takei, Yasuyoshi

AU - Di Tullio, Marco R.

AU - Homma, Shunichi

AU - Boden-Albala, Bernadette

AU - Rundek, Tatjana

AU - Sacco, Ralph L

AU - Berry, Grace

AU - Liu, Rui

AU - Jin, Zhezhen

AU - Eguchi, Kazuo

AU - Elkind, Mitchell S V

PY - 2009/7/1

Y1 - 2009/7/1

N2 - BackgroundAlthough inflammatory markers may be associated with risk of cardiovascular events, few data are available regarding these markers and their association with left ventricular hypertrophy (LVH). We sought to evaluate whether inflammatory markers were independently associated with LVH in a multiethnic population in northern Manhattan.MethodsA population-based cross-sectional study was conducted in 660 participants without stroke, who had undergone both transthoracic echocardiography and testing for soluble tumor necrosis factor receptor (sTNFR) 1, interleukin (IL)-6, and high-sensitivity C-reactive protein (hsCRP). LV mass was calculated according to an established formula. LVH was defined as LV mass >90th percentile of the participants.ResultsThe mean age was 67.4 ± 8.8 years, 35.5% were men, 61.7% were Hispanic, 19.7% were black, and 18.6% were white. In univariate analyses, hsCRP, IL-6, and sTNFR1 were significantly associated with LV mass. Multiple linear regression analyses demonstrated that sTNFR1 (P ≤ 0.0008) was associated with LV mass after adjusting for demographic and medical risk factors, but hsCRP and IL-6 were not. When all markers were included in the same model, sTNFR1 remained significant, but hsCRP and IL-6 did not. Compared with the lowest quartile of sTNFR1, those in the highest quartile were more likely to have LVH (odds ratio ≤ 1.84, 95% confidence interval, 0.97-3.64, P ≤ 0.06).ConclusionssTNFR1, but not hsCRP nor IL-6, is independently associated with increased LV mass. Chronic subclinical inflammation including the TNFR1-associated system may contribute to LVH.

AB - BackgroundAlthough inflammatory markers may be associated with risk of cardiovascular events, few data are available regarding these markers and their association with left ventricular hypertrophy (LVH). We sought to evaluate whether inflammatory markers were independently associated with LVH in a multiethnic population in northern Manhattan.MethodsA population-based cross-sectional study was conducted in 660 participants without stroke, who had undergone both transthoracic echocardiography and testing for soluble tumor necrosis factor receptor (sTNFR) 1, interleukin (IL)-6, and high-sensitivity C-reactive protein (hsCRP). LV mass was calculated according to an established formula. LVH was defined as LV mass >90th percentile of the participants.ResultsThe mean age was 67.4 ± 8.8 years, 35.5% were men, 61.7% were Hispanic, 19.7% were black, and 18.6% were white. In univariate analyses, hsCRP, IL-6, and sTNFR1 were significantly associated with LV mass. Multiple linear regression analyses demonstrated that sTNFR1 (P ≤ 0.0008) was associated with LV mass after adjusting for demographic and medical risk factors, but hsCRP and IL-6 were not. When all markers were included in the same model, sTNFR1 remained significant, but hsCRP and IL-6 did not. Compared with the lowest quartile of sTNFR1, those in the highest quartile were more likely to have LVH (odds ratio ≤ 1.84, 95% confidence interval, 0.97-3.64, P ≤ 0.06).ConclusionssTNFR1, but not hsCRP nor IL-6, is independently associated with increased LV mass. Chronic subclinical inflammation including the TNFR1-associated system may contribute to LVH.

UR - http://www.scopus.com/inward/record.url?scp=67649311829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649311829&partnerID=8YFLogxK

U2 - 10.1038/ajh.2009.79

DO - 10.1038/ajh.2009.79

M3 - Article

C2 - 19390513

AN - SCOPUS:67649311829

VL - 22

SP - 763

EP - 769

JO - Journal of clinical hypertension

JF - Journal of clinical hypertension

SN - 0895-7061

IS - 7

ER -